We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.00 | 28.00 | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/2/2019 14:27 | The last half hour here will be interesting today. | marbill73 | |
20/2/2019 14:25 | pmsl EL wakey wakey your sleep talking | datait | |
20/2/2019 14:24 | Think the Company will use this rise to place stock at 1p | bigboots | |
20/2/2019 14:11 | pmsl there goes EL knows it all NOT HAHAHAHA | datait | |
20/2/2019 14:10 | fill your boots and big knickers | datait | |
20/2/2019 14:08 | Integumen has multiple revenue pipelines... Skin Microbiome: Labskin Animal-Free Lab-grown, simulated human skin, for testing cosmetic and pharma products for dandruff, acne, fungal and bacterial infection Innovenn Skin Science Labskin Certification of products, and training of Lab technicians. Virtual Lab services for cosmetic, skincare and pharma companies Stoer For Men Cosmetics Range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of aging WoundPhase Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing Micro Biomaterials: Omega 3 from Algae Major health benefits for global human population explosion. Alternative production to extraction from declining global fish stocks Bio-Plastic Ingredients Solution to dumping 8 million tonnes of waste plastic in the oceans each year. Alternative biodegradable plastic solution Algzym CBD Technology Low-cost Solvent-Free commercial scale solution to the production of Omega-3 oils from micro-algae and CBD oils from hemp Cellulac Commercial License Partners of the Algzym Technology platform for bio-based oils, including Omega 3, CBD and bio-plastic ingredients | someuwin | |
20/2/2019 13:55 | How much is this product.? Its usually the thing that kills these companies but its very early days yet | elcapital2018 | |
20/2/2019 13:55 | Daitait on what do you base that? | herb clark | |
20/2/2019 13:54 | I can see this soar past 4p soon. | datait | |
20/2/2019 13:49 | The company has been transformed and should grow strongly from these bombed out levels. Gerard Brandon (Chief Executive Officer) commented: "Integumen has been transformed to become a vertically integrated business. Other technology collaboration partners in artificial intelligence, clinical research, medical device and life science companies are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies. We no longer simply manufacture and sell skin-testing kits. We are a clinical product development Company. We combine data analytics with access to therapeutic operational expertise and offer solutions for our clients from regulatory approvals right through to marketing fully tested ingredients that have been certified on our physical testing living human tissue." | someuwin | |
20/2/2019 13:39 | Did you get your entry price? | glenbo1 | |
20/2/2019 13:29 | Biggest spike yet to be seen. | marbill73 | |
20/2/2019 13:20 | Integumen soars as CBD-infused skin creams kill 99% of bacteria Shares in Integumen PLC (LON:SKIN) have soared after its cannabinoid-infused skin creams killed more than 99% of skin bacteria during in-lab testing. Management said the results, more of which are planned, “provide clear evidence” of how the addition of CBD to skin-care treatments and cosmetics can lower the incidence of skin disease. The tests, which included formulations of Integumen’s STOER men’s skincare range, were carried out on bacteria known to cause infections and some of which are resistant to antibiotics. To test its creams, Integumen used Labskin – a special laboratory-grown human skin that takes away the need for animal testing. Integumen owns a 9.35% stake in Labskin. Integumen shares more than 40% to 1.3p on the back of the news. | someuwin | |
20/2/2019 13:16 | Good choice | datait | |
20/2/2019 13:14 | https://youtu.be/8HW | marbill73 | |
20/2/2019 13:13 | https://youtu.be/vjD | marbill73 | |
20/2/2019 13:13 | Not enough stock should shoot up soon enough | datait | |
20/2/2019 12:49 | Dont buy for the divi as it will fall on the day anyway | datait | |
20/2/2019 12:46 | I agree Dave | glenbo1 | |
20/2/2019 12:43 | All I'm seeing now is filtered posts apart from a few regulars. Pump and dumpers cannot hold stocks hence it's drifting back. Cracking price 1.3p short term to take profits at | dave4545 | |
20/2/2019 12:37 | Best to buy in a few days at 1p | letmepass |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions